Tapentadol is a centrally acting synthetic analgesic with a dual mechanism of action. It acts as a mu-opioid receptor agonist and also inhibits norepinephrine reuptake, leading to enhanced pain modulation. Tapentadol is approximately 18 times less potent than morphine in terms of binding affinity to human mu-opioid receptors. Its analgesic effects can be blocked by selective mu-opioid antagonists such as naloxone. Tapentadol does not have a clinically significant effect on the QT interval.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Dosage & Administration

Dosage should be individualized based on pain severity, prior analgesic experience, and patient response.

• Recommended dose: 50 mg, 75 mg, or 100 mg every 4 to 6 hours, depending on pain intensity

• On the first day, a second dose may be administered as soon as one hour after the first dose if pain relief is inadequate

• Subsequent dosing should be adjusted to maintain adequate analgesia with acceptable tolerability

Maximum Dose:

• First day: Not more than 700 mg/day

• Subsequent days: Not more than 600 mg/day

Doses exceeding these limits have not been studied and are not recommended.

Drug Interactions

• Increased risk of serotonin syndrome with TCAs, SSRIs, SNRIs, triptans, and other monoaminergic drugs

• Enhanced sedative and respiratory depressant effects with benzodiazepines, barbiturates, antipsychotics, H1-antihistamines, other opioids, and alcohol

• Increased risk of dependence with mixed or partial mu-opioid agonists (e.g., nalbuphine, pentazocine, buprenorphine)

• Increased systemic exposure with strong UGT1A6, UGT1A9, and UGT2B7 inhibitors

• Reduced efficacy with strong enzyme inducers such as rifampicin and phenobarbital

Contraindications

Topita SR 100 mg is contraindicated in patients with:

• Impaired pulmonary function

• Acute or severe bronchial asthma or hypercapnia in unmonitored settings

• Suspected or confirmed paralytic ileus

Side Effects

Possible adverse effects include:

• Cardiovascular: increased or decreased heart rate, decreased blood pressure

• Neurological: dizziness, sedation, memory impairment, ataxia, seizures, syncope

• Gastrointestinal: abdominal discomfort, impaired gastric emptying

• Sensory: hypoesthesia, paresthesia, visual disturbances

• Others: edema, hypersensitivity reactions, urticaria, drug withdrawal syndrome

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Pregnancy & Lactation

• Pregnancy Category C: Use only if the potential benefit justifies the potential risk to the fetus

• Neonates born to mothers using tapentadol should be monitored for respiratory depression

• Use during lactation should be guided strictly by physician advice

Precautions & Warnings

• Use with caution in patients with respiratory disorders such as asthma or COPD

• Caution is required in patients with sleep apnea, myxedema, kyphoscoliosis, or CNS depression

• Concomitant use with CNS depressants may result in additive sedation and respiratory depression

Overdose Effects

Symptoms:
Vomiting, miosis, cardiovascular collapse, altered consciousness, convulsions, and respiratory depression up to respiratory arrest

Management:

• Ensure airway patency and provide assisted ventilation

• Consider activated charcoal or gastric lavage within 2 hours of ingestion

• Administer opioid antagonists such as naloxone when indicated

Use in Special Populations

• Pediatric: Safety and efficacy in patients under 18 years have not been established

• Elderly: Start at the lower end of the dosing range

• Renal Impairment: Not established in severe renal disease

• Hepatic Impairment: Use with caution in moderate impairment; not studied in severe hepatic impairment

Storage Conditions

• Store in a cool and dry place

• Protect from light and moisture

• Keep out of reach of children

Mode of Action

Topita SR 100 mg provides analgesia through combined mu-opioid receptor agonism and inhibition of norepinephrine reuptake, resulting in effective pain control without significant QT interval prolongation.